skip to main content

    Updated Visitor Guidelines

 

MENU

 

The Adolescent and Young Adult Oncology Program helps support cancer patients

The Adolescent and Young Adult (AYA) Oncology program, established at C.S. Mott Children’s Hospital and the Rogel Cancer Center is feared toward those ages 13 to 39. The initiative is made up of physicians, social workers and researchers with expertise in adult, adolescent or pediatric medicine.

Dual-eligible cancer patients should seek end-of-life care at cancer centers

Cancer centers and/or health care systems that prioritize coordination and communication provide higher-quality end-of-life care for cancer patients who are eligible for both Medicare and Medicaid, University of Michigan researchers found.

With $13M grant, U-M researchers will track cancer risk from environmental exposures

Heavy metals like lead, industrial pollution from steel mills, coal-fired power plants or oil refineries, “forever chemicals” called PFAS that do not break down in the environment.

Metformin shows promise against rare childhood brain tumor in laboratory studies

Metformin, a drug commonly prescribed against diabetes, holds promise against a rare type of childhood brain tumor in laboratory studies, an international team of researchers led by the Rogel Cancer Center report in Science Translational Medicine.

Targeting a mutation found in all gliomas may be the key immunotherapy success

A common mutation in gliomas sensitizes them to immunotherapy, a finding which researchers believe could have broader therapeutic implications for all glioma patients.

Women with genetic mutations fare no worse with breast or ovarian cancer, study finds

Women newly diagnosed with breast or ovarian cancer who are also carriers of cancer-associated mutations like BRCA1 or BRCA2 are no more likely to die of their tumors than those who don’t have the mutations, according to a new study.

Example

This is the content area you can edit.

Underneath the left-hand menu, you'll see a note to sign-up for your newsletter. This is a block and I can add other blocks like this on the left or down at the bottom of the page (above the footer).

It's possible to embed videos, photographs, and graphics. If we embed something that isn't ours, we need to get permission and give credit.

Friese appointed to National Cancer Advisory Board

President Joseph Biden named Christopher Friese, Ph.D., R.N., among seven new members of the National Cancer Advisory Board, an elite group of 18 cancer clinicians and researchers who play an important role in guiding the director of the National Cancer Institute in setting the course for the national cancer research program. Friese’s term will last six years.

Blood Enzyme Activity Level May Indicate Which Breast Cancers Are Slow Growing

Researchers with the SWOG Cancer Research Network have found that patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen treatment live longer and go longer without their disease progressing than patients with high levels.

Pages